Ortoma AB Series B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more
Ortoma AB Series B (ORT-B) - Total Assets
Latest total assets as of September 2025: Skr179.96 Million SEK
Based on the latest financial reports, Ortoma AB Series B (ORT-B) holds total assets worth Skr179.96 Million SEK as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ortoma AB Series B - Total Assets Trend (2021–2024)
This chart illustrates how Ortoma AB Series B’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ortoma AB Series B - Asset Composition Analysis
Current Asset Composition (December 2024)
Ortoma AB Series B's total assets of Skr179.96 Million consist of 26.9% current assets and 73.1% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 9.9% |
| Accounts Receivable | Skr17.81 Million | 9.8% |
| Inventory | Skr8.71 Million | 4.8% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr132.14 Million | 73.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Ortoma AB Series B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ortoma AB Series B's current assets represent 26.9% of total assets in 2024, an increase from 13.4% in 2021.
- Cash Position: Cash and equivalents constituted 9.9% of total assets in 2024, up from 9.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 73.0% of total assets, a decrease from 86.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 73.0% of total assets.
Ortoma AB Series B Competitors by Total Assets
Key competitors of Ortoma AB Series B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Japan Vietnam Medical Instrument JSC
VN:JVC
|
Vietnam | ₫587.02 Billion |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
Orthopediatrics Corp
NASDAQ:KIDS
|
USA | $523.08 Million |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Kelyniam Global Inc
PINK:KLYG
|
USA | $1.73 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$6.94 Million |
|
Phase Holographic Imaging PHI AB (publ)
F:L5W
|
Germany | €36.91 Million |
|
Standard Biotools Inc
NASDAQ:LAB
|
USA | $539.64 Million |
Ortoma AB Series B - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Ortoma AB Series B generates 0.27x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Ortoma AB Series B is currently not profitable relative to its asset base.
Ortoma AB Series B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.86 | 4.41 | 3.80 |
| Quick Ratio | 3.02 | 3.46 | 3.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr41.90 Million | Skr 38.40 Million | Skr 38.43 Million |
Ortoma AB Series B - Advanced Valuation Insights
This section examines the relationship between Ortoma AB Series B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.90 |
| Latest Market Cap to Assets Ratio | 0.10 |
| Asset Growth Rate (YoY) | -5.9% |
| Total Assets | Skr180.98 Million |
| Market Capitalization | $18.69 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ortoma AB Series B's assets below their book value (0.10 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Ortoma AB Series B's assets decreased by 5.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ortoma AB Series B (2021–2024)
The table below shows the annual total assets of Ortoma AB Series B from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr180.98 Million | -5.90% |
| 2023-12-31 | Skr192.33 Million | +27.11% |
| 2022-12-31 | Skr151.31 Million | +12.93% |
| 2021-12-31 | Skr133.99 Million | -- |